drugset / Trial / NCT02922452

A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects

NCT02922452

Phase 1 Completed 16 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-labelBasic science

Summary

This study is to evaluate the effect of dilitazem on the single-dose PK of BMS-986141 with parameters like Cmax, AUC(INF), and AUC(0-T).

Timeline

Start
2016-09
Primary completion
2016-11
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986141 Small molecule
Subject Dilitazem Unknown

Indications